BMEA vs CLX · $94.7M cap vs P/E 15, rev $7.10B
Biomea Fusion Inc (BMEA) versus The Clorox Company (CLX) — a side-by-side from cached financials, not a winner call.
Biomea Fusion Inc (BMEA) is a biotechnology company listed on US.
The Clorox Company (CLX) is a household & personal products company listed on US.
BMEA does not have a complete income-statement cache yet.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. Revenue was up 0.2% from 2024-06-30 to 2025-06-30. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
BMEA currently screens at market cap $94.7M. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
Not investment advice. Open the BMEA and CLX stock pages for the full models.
Not investment advice.